MedTrace Logo

Transbronchial Ablation for Peripheral Lung Tumor

NCT02972177 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-02-18

No results posted yet for this study

Summary

The objective of the study was to evaluate the efficacy and safety of navigation bronchoscopy guided transbronchial ablation for the treatment of inoperable peripheral lung tumor.

Conditions

Interventions

PROCEDURE

Radiofrequency ablation

Transbronchial radiofrequency ablation will be performed under the guidance of navigation bronchoscopy.

PROCEDURE

Microwave ablation

Transbronchial microwave ablation will be performed under the guidance of navigation bronchoscopy.

Sponsors & Collaborators

  • Shanghai Chest Hospital

    lead OTHER

Principal Investigators

  • Jiayuan Sun, MD,PhD · Shanghai Chest Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-07
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02972177 on ClinicalTrials.gov